Zobrazeno 1 - 10
of 312
pro vyhledávání: '"Jolanda M De Vries"'
Autor:
Kimberley RG Cortenbach, Alexander HJ Staal, Teske Schoffelen, Mark AJ Gorris, Lieke L Van der Woude, Anne FM Jansen, Paul Poyck, Robert Jan Van Suylen, Peter C Wever, Chantal P Bleeker-Rovers, Mangala Srinivas, Konnie M Hebeda, Marcel van Deuren, Jos W Van der Meer, Jolanda M De Vries, Roland RJ Van Kimmenade
Publikováno v:
eLife, Vol 11 (2022)
Background: Chronic Q fever is a zoonosis caused by the bacterium Coxiella burnetii which can manifest as infection of an abdominal aortic aneurysm (AAA). Antibiotic therapy often fails, resulting in severe morbidity and high mortality. Whereas previ
Externí odkaz:
https://doaj.org/article/1e24405511e940f389f690a5a298a7af
Autor:
Jacob M van Laar, Anna de Goede, Gerty Schreibelt, Arie Jan Stoppelenburg, I Jolanda M de Vries, Paco Welsing, Bouke Koeneman, Evert-Jan Breman, Laureen Lammers, Tjitske Duiveman-de Boer, Willem van Eden, Paul Leufkens, Femke Broere
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Introduction In rheumatoid arthritis (RA), immunosuppressive therapies may achieve symptomatic relief, but do not induce long-term, drug-free remission. Meanwhile, the lifelong use of immunosuppressive drugs confers increased risk for malignancy and
Externí odkaz:
https://doaj.org/article/048d163ecbc2444592ca57a8e33b4efc
Autor:
Lotte Bakkerus, Beatriz Subtil, Hetty J. Bontkes, Elske C. Gootjes, Martine Reijm, Manon Vullings, Kiek Verrijp, John-Melle Bokhorst, Carmen Woortman, Iris D. Nagtegaal, Marianne A. Jonker, Hans J. van der Vliet, Cornelis Verhoef, Mark A.J. Gorris, I. Jolanda M. de Vries, Tanja D. de Gruijl, Henk M.W. Verheul, Tineke E. Buffart, Daniele V. F. Tauriello
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Colorectal cancer (CRC) raises considerable clinical challenges, including a high mortality rate once the tumor spreads to distant sites. At this advanced stage, more accurate prediction of prognosis and treatment outcome is urgently needed. The role
Externí odkaz:
https://doaj.org/article/d840e76947914521ba035fcfccc6eb05
Autor:
Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal, Wouter W. van Willigen, Simone Hins-de Bree, Anna L. de Goede, Annemiek J. de Boer, Kevin J. H. Bos, Tjitske Duiveman-de Boer, Michel A. M. Olde Nordkamp, Tom G. M. van Oorschot, Carlijn J. Popelier, Jeanne M. Pots, Nicole M. Scharenborg, Mandy W. M. M. van de Rakt, Valeska de Ruiter, Wilmy S. van Meeteren, Michelle M. van Rossum, Sandra J. Croockewit, Bouke J. Koeneman, Jeroen H. A. Creemers, Inge M. N. Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A. van der Veldt, Dirk J. van Grünhagen, Johanna E. M. Werner, Johannes J. Bonenkamp, John B. A. G. Haanen, Marye J. Boers-Sonderen, Rutger H. T. Koornstra, Martijn F. Boomsma, Erik H. J. Aarntzen, Martin Gotthardt, James Nagarajah, Theo J. M. de Witte, Carl G. Figdor, Johannes H. W. de Wilt, Johannes Textor, Jan Willem B. de Groot, Winald R. Gerritsen, I. Jolanda M. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Autologous natural dendritic cells (nDCs) treatment can induce tumor-specific immune responses and clinical responses in cancer patients. In this phase III clinical trial (NCT02993315), 148 patients with resected stage IIIB/C melanoma were r
Externí odkaz:
https://doaj.org/article/245269452ff04a81b46a9a6846fb6516
Autor:
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, Mélanie Bourgin, Gerty Schreibelt, Sylvère Durand, Roxanne Birebent, Marine Fidelle, Cissé Sow, Fanny Aprahamian, Paolo Manghi, Michal Punčochář, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Damien Drubay, Alexander M. M. Eggermont, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Lisa Derosa, Kalijn F. Bol, I. Jolanda M. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Tumor immunosurveillance plays a major role in melanoma, prompting the development of immunotherapy strategies. The gut microbiota composition, influencing peripheral and tumoral immune tonus, earned its credentials among predictors of survi
Externí odkaz:
https://doaj.org/article/93008ed84ad54d8ba4a63ee21aaebb08
Autor:
Niels eSchaft, miriam eCoccoris, Joost eDrexhage, Christiaan eKnoop, Jolanda M de Vries, Gosse J Adema, Reno eDebets
Publikováno v:
Frontiers in Immunology, Vol 4 (2013)
Altered peptide ligands (APLs) provide useful tools to study T cell activation and potentially direct immune responses to improve treatment of cancer patients. To better understand and exploit APLs, we studied the relationship between APLs and T cell
Externí odkaz:
https://doaj.org/article/0b72aa6763a74c919886709f203476f2
Autor:
Bouke J. Koeneman, Gerty Schreibelt, Mark A. J. Gorris, Simone Hins - de Bree, Harm Westdorp, Petronella B. Ottevanger, I. Jolanda M. de Vries
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMetastatic endometrial cancer (mEC) continues to have a poor prognosis despite the introduction of several novel therapies including immune checkpoints inhibitors. Dendritic cell (DC) vaccination is known to be a safe immunotherapeutic moda
Externí odkaz:
https://doaj.org/article/ba90a72256674e0e9275079eb7a990e4
Autor:
Jorge Cuenca-Escalona, Beatriz Subtil, Alba Garcia-Perez, Alessandra Cambi, I. Jolanda M. de Vries, Georgina Flórez-Grau
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Tumors educate their environment to prime the occurrence of suppressive cell subsets, which enable tumor evasion and favors tumor progression. Among these, there are the myeloid-derived suppressor cells (MDSCs), their presence being associated with t
Externí odkaz:
https://doaj.org/article/95a90294531543d0b988c583f7fe6799
Autor:
Jeroen H. A. Creemers, Ankur Ankan, Kit C. B. Roes, Gijs Schröder, Niven Mehra, Carl G. Figdor, I. Jolanda M. de Vries, Johannes Textor
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Late-stage cancer immunotherapy trials often lead to unusual survival curve shapes, like delayed curve separation or a plateauing curve in the treatment arm. It is critical for trial success to anticipate such effects in advance and adjust t
Externí odkaz:
https://doaj.org/article/e3acd50fd4b54c859df232a022fd9f30
Autor:
Noémi Anna Nagy, Fernando Lozano Vigario, Rinske Sparrius, Toni M. M. van Capel, Ronald van Ree, Sander W. Tas, I. Jolanda M. de Vries, Teunis B. H. Geijtenbeek, Bram Slütter, Esther C. de Jong, for the DC4Balance consortium
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionNanomedicine provides a promising platform for manipulating dendritic cells (DCs) and the ensuing adaptive immune response. For the induction of regulatory responses, DCs can be targeted in vivo with nanoparticles incorporating tolerogeni
Externí odkaz:
https://doaj.org/article/ab1fdaff4c404832a67c0aa30a27e388